Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.

Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.
复制标题

DOI:
10.1177/1087057113478655
复制
发表时间:
2013-07
影响因子:
--
通讯作者:
Rogers MS
Rogers MS
中科院分区:
化学3区
文献类型:
--
作者:
Cryan LM;Habeshian KA;Caldwell TP;Morris MT;Ackroyd PC;Christensen KA;Rogers MS

文献摘要

参考文献

被引文献

相似文献

肿瘤标志物内皮8(TEM8)是炭疽毒素保护性抗原(PA)的受体。与正常血管相比,TEM8在肿瘤血管内皮细胞上表达上调。许多研究表明,TEM8在发育和肿瘤血管生成中起着关键作用。我们还表明,以突变形式的PA靶向炭疽受体可以抑制体内血管生成和肿瘤形成。在这里,我们描述了高通量荧光共振能量转移分析的发展和测试,以确定强烈抑制PA和TEM8相互作用的分子。我们描述的分析是灵敏和稳健的,Z素值为0.8。初步筛选了2310个已知的生物活性文库化合物,确定ebselen和硫柳汞是TEM8-PA相互作用的抑制剂。这些分子都含有半胱氨酸-反应性过渡金属,补充研究表明,它们相互作用的抑制是由于TEM8胞外区的半胱氨酸残基的修饰。这是鉴定TEM8抑制剂的高通量筛选试验的第一次展示,具有抗炭疽和抗血管生成疾病的潜在应用。
Tumor marker endothelial 8 (TEM8) is a receptor for the Protective Antigen (PA) component of anthrax toxin. TEM8 is upregulated on endothelial cells lining the blood vessels within tumors, compared to normal blood vessels. A number of studies have demonstrated a pivotal role for TEM8 in developmental and tumor angiogenesis. We have also shown that targeting the anthrax receptors with a mutated form of PA inhibits angiogenesis and tumor formation in vivo. Here we describe the development and testing of a high-throughput fluorescence resonance energy transfer assay to identify molecules that strongly inhibit the interaction of PA and TEM8. The assay we describe is sensitive and robust, with a Z-prime value of 0.8. A preliminary screen of 2310 known bioactive library compounds identified ebselen and thimerosal as inhibitors of the TEM8-PA interaction. These molecules each contain a cysteine-reactive transition metal, and complimentary studies indicate that their inhibition of interaction is due to modification of a cysteine residue in the TEM8 extracellular domain. This is the first demonstration of a high-throughput screening assay that identifies inhibitors of TEM8, with potential application for anti-anthrax and anti-angiogenic diseases.
DOI: 10.1073/pnas.0431098100
发表时间: 2003-04-29
影响因子: 11.1
作者:
Scobie, HM;Rainey, GJA;Young, JAT
通讯作者: Young, JAT
DOI: 10.1038/nm.1877
发表时间: 2008-11
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1158/0008-5472.can-07-0829
发表时间: 2007-10-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Rogers, Michael S.;Christensen, Kenneth A.;D'Amato, Robert J.
通讯作者: D'Amato, Robert J.
DOI: 10.1158/0008-5472.can-09-1086
发表时间: 2009-08-01
期刊: Cancer research
影响因子: 11.2
作者:
Cullen M;Seaman S;Chaudhary A;Yang MY;Hilton MB;Logsdon D;Haines DC;Tessarollo L;St Croix B
通讯作者: St Croix B
DOI: 10.1086/432731
发表时间: 2005-09-15
影响因子: 6.4
作者:
Scobie, HM;Thomas, D;Manchester, M
通讯作者: Manchester, M